Embecta (EMBC) Amortization of Deferred Charges (2022 - 2026)
Embecta (EMBC) posted Amortization of Deferred Charges of $1.9 million for Q1 2026, little changed sequentially from $1.9 million in Q4 2025, and down 5.0% YoY from $2.0 million in Q1 2025.
Embecta (EMBC) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Embecta has reported Amortization of Deferred Charges for 5 years, with the latest figure at $1.9 million in Q1 2026.
- Quarterly Amortization of Deferred Charges fell 5.0% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (up 12.82% YoY) and the FY2025 annual result came in at $9.1 million, up 31.88% from the prior year.
- Amortization of Deferred Charges steadied at $1.9 million in Q1 2026 per EMBC's latest filing, from $1.9 million in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $2.6 million in Q3 2025 and troughed at $100000.0 in Q1 2022.
- A 5-year average of $1.7 million and a median of $1.6 million in 2022 frame the typical range for Amortization of Deferred Charges.
- The widest YoY moves for Amortization of Deferred Charges: up 1500.0% in 2023, down 11.11% in 2023.
- Over 5 years, Amortization of Deferred Charges stood at $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then jumped by 31.25% to $2.1 million in 2024, then fell by 9.52% to $1.9 million in 2025, then changed by 0.0% to $1.9 million in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $1.9 million, $1.9 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.40 Mn |
| Jun 30, 2026 | 1.40 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.60 Mn |